Patent · US Active

Substituted naphthyridine and quinoline compounds as MAO inhibitors

US9150572B2 · kind B2 · utility

2Cited by
7References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 11, 2014
Grant dateOct 6, 2015
Priority date—
Expiry dateMar 11, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a chemical entity of Formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.